my personal edition > schizophrenia > news


  E-Mail this item to a colleague

TopAbstracts in Schizophrenia 10/29/2009

TopAbstracts™ in Schizophrenia are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide™ newsletter or visited a website Powered by Doctor's Guide™ in the past 14 days. Over 2000 peer-reviewed journals are covered by TopAbstracts.

TopAbstracts - Past 14 days

• Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission - (Int J Neuropsychopharmacol)
• Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies - (Int J Clin Pract)
• Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study - (Expert Rev Neurother)
• Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic - (Int J Clin Pract)
• In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation - (Br J Clin Pharmacol)

E-Mail this item to a colleague

To print, use this version